• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

v-crk癌基因产物与含磷酸酪氨酸的蛋白质及蛋白激酶活性的关联。

Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity.

作者信息

Mayer B J, Hanafusa H

机构信息

Rockefeller University, New York, NY 10021.

出版信息

Proc Natl Acad Sci U S A. 1990 Apr;87(7):2638-42. doi: 10.1073/pnas.87.7.2638.

DOI:10.1073/pnas.87.7.2638
PMID:1690891
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC53745/
Abstract

An antiserum specific for P47gag-crk, the oncogene product of avian sarcoma virus CT10, was used to investigate possible crk-binding proteins. In in vitro kinase assays, four proteins were phosphorylated in anti-crk immunoprecipitates. Tyrosine, serine, and threonine residues were phosphorylated. A number of tyrosine-phosphorylated proteins were identified in anti-crk immunoprecipitates of 32P-labeled cells, including the three major phosphotyrosine-containing proteins of CT10-infected cells. These three proteins also bound to bacterially synthesized crk protein. These results suggest that the crk transforming protein can stably associate with both endogenous kinases and cellular kinase substrates.

摘要

一种针对禽肉瘤病毒CT10的致癌基因产物P47gag-crk的抗血清,被用于研究可能的crk结合蛋白。在体外激酶分析中,抗crk免疫沉淀物中有四种蛋白质发生了磷酸化。酪氨酸、丝氨酸和苏氨酸残基都被磷酸化。在32P标记细胞的抗crk免疫沉淀物中鉴定出了许多酪氨酸磷酸化蛋白,包括CT10感染细胞中的三种主要含磷酸酪氨酸的蛋白。这三种蛋白也与细菌合成的crk蛋白结合。这些结果表明,crk转化蛋白可以与内源性激酶和细胞激酶底物稳定结合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/0e787cdb4765/pnas01032-0267-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/94e12dffe179/pnas01032-0265-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/eb001a9636d0/pnas01032-0265-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/4f4185d0837c/pnas01032-0265-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/91f72037b119/pnas01032-0265-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/2e406fdbaa26/pnas01032-0266-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/593e1b18bed1/pnas01032-0266-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/62b58ef76701/pnas01032-0266-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/7510cd5f49c8/pnas01032-0266-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/d3895354f529/pnas01032-0266-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/cd856c097053/pnas01032-0266-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/0e787cdb4765/pnas01032-0267-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/94e12dffe179/pnas01032-0265-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/eb001a9636d0/pnas01032-0265-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/4f4185d0837c/pnas01032-0265-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/91f72037b119/pnas01032-0265-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/2e406fdbaa26/pnas01032-0266-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/593e1b18bed1/pnas01032-0266-b.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/62b58ef76701/pnas01032-0266-c.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/7510cd5f49c8/pnas01032-0266-d.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/d3895354f529/pnas01032-0266-e.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/cd856c097053/pnas01032-0266-f.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9391/53745/0e787cdb4765/pnas01032-0267-a.jpg

相似文献

1
Association of the v-crk oncogene product with phosphotyrosine-containing proteins and protein kinase activity.v-crk癌基因产物与含磷酸酪氨酸的蛋白质及蛋白激酶活性的关联。
Proc Natl Acad Sci U S A. 1990 Apr;87(7):2638-42. doi: 10.1073/pnas.87.7.2638.
2
Binding of transforming protein, P47gag-crk, to a broad range of phosphotyrosine-containing proteins.转化蛋白P47gag-crk与多种含磷酸酪氨酸的蛋白的结合。
Science. 1990 Jun 22;248(4962):1537-9. doi: 10.1126/science.1694307.
3
Identification and characterization of a high-affinity interaction between v-Crk and tyrosine-phosphorylated paxillin in CT10-transformed fibroblasts.在CT10转化的成纤维细胞中鉴定和表征v-Crk与酪氨酸磷酸化桩蛋白之间的高亲和力相互作用。
Mol Cell Biol. 1993 Aug;13(8):4648-56. doi: 10.1128/mcb.13.8.4648-4656.1993.
4
Characterization of p47gag-crk, a novel oncogene product with sequence similarity to a putative modulatory domain of protein-tyrosine kinases and phospholipase C.p47gag-crk的特性,一种与蛋白酪氨酸激酶和磷脂酶C的假定调节结构域具有序列相似性的新型癌基因产物。
Cold Spring Harb Symp Quant Biol. 1988;53 Pt 2:907-14. doi: 10.1101/sqb.1988.053.01.104.
5
Purification and characterization of P47gag-crk expressed in insect cells.在昆虫细胞中表达的P47gag-crk的纯化与特性分析
J Biol Chem. 1990 Jul 15;265(20):12000-4.
6
Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.致癌病毒酪氨酸蛋白激酶的大多数底物在正常细胞中可被细胞酪氨酸蛋白激酶磷酸化。
Oncogene Res. 1988 Sep;3(2):105-15.
7
Biological and biochemical activity of v-Crk chimeras containing the SH2/SH3 regions of phosphatidylinositol-specific phospholipase C-gamma and Src.包含磷脂酰肌醇特异性磷脂酶C-γ和Src的SH2/SH3区域的v-Crk嵌合体的生物学和生化活性
J Virol. 1992 Jan;66(1):115-21. doi: 10.1128/JVI.66.1.115-121.1992.
8
Mutagenic analysis of the v-crk oncogene: requirement for SH2 and SH3 domains and correlation between increased cellular phosphotyrosine and transformation.v-crk癌基因的诱变分析:SH2和SH3结构域的要求以及细胞磷酸酪氨酸增加与转化之间的相关性。
J Virol. 1990 Aug;64(8):3581-9. doi: 10.1128/JVI.64.8.3581-3589.1990.
9
Tyrosine-phosphorylated epidermal growth factor receptor and cellular p130 provide high affinity binding substrates to analyze Crk-phosphotyrosine-dependent interactions in vitro.酪氨酸磷酸化的表皮生长因子受体和细胞p130提供了高亲和力结合底物,用于在体外分析Crk磷酸酪氨酸依赖性相互作用。
J Biol Chem. 1992 May 25;267(15):10588-95.
10
Identification of domains of the v-crk oncogene product sufficient for association with phosphotyrosine-containing proteins.确定v-crk癌基因产物中足以与含磷酸酪氨酸蛋白结合的结构域。
Mol Cell Biol. 1991 Mar;11(3):1607-13. doi: 10.1128/mcb.11.3.1607-1613.1991.

引用本文的文献

1
Crk and CrkL as Therapeutic Targets for Cancer Treatment.Crk 和 CrkL 作为癌症治疗的治疗靶点。
Cells. 2021 Mar 27;10(4):739. doi: 10.3390/cells10040739.
2
p130Cas scaffolds the signalosome to direct adaptor-effector cross talk during Kaposi's sarcoma-associated herpesvirus trafficking in human microvascular dermal endothelial cells.p130Cas在卡波西肉瘤相关疱疹病毒在人真皮微血管内皮细胞中运输期间,构建信号体以指导衔接蛋白-效应器之间的串扰。
J Virol. 2014 Dec;88(23):13858-78. doi: 10.1128/JVI.01674-14. Epub 2014 Sep 24.
3
Receptor tyrosine kinases: legacy of the first two decades.

本文引用的文献

1
Analysis of the catalytic domain of phosphotransferase activity of two avian sarcoma virus-transforming proteins.两种禽肉瘤病毒转化蛋白磷酸转移酶活性催化结构域的分析
J Biol Chem. 1984 Apr 10;259(7):4550-7.
2
Polyoma virus transforming protein associates with the product of the c-src cellular gene.多瘤病毒转化蛋白与c-src细胞基因的产物相关联。
Nature. 1983;303(5916):435-9. doi: 10.1038/303435a0.
3
Structural and functional domains of the Rous sarcoma virus transforming protein (pp60src).劳氏肉瘤病毒转化蛋白(pp60src)的结构域与功能域
受体酪氨酸激酶:头二十年的传承。
Cold Spring Harb Perspect Biol. 2014 Mar 1;6(3):a008912. doi: 10.1101/cshperspect.a008912.
4
Interaction of crk with Myosin-1c participates in fibronectin-induced cell spreading.Crk 与肌球蛋白-1c 的相互作用参与纤连蛋白诱导的细胞铺展。
Int J Biol Sci. 2013 Aug 15;9(8):778-91. doi: 10.7150/ijbs.6459. eCollection 2013.
5
SRC points the way to biomarkers and chemotherapeutic targets.SRC为生物标志物和化疗靶点指明了方向。
Genes Cancer. 2012 May;3(5-6):426-35. doi: 10.1177/1947601912458583.
6
Modular evolution of phosphorylation-based signalling systems.磷酸化信号系统的模块化进化。
Philos Trans R Soc Lond B Biol Sci. 2012 Sep 19;367(1602):2540-55. doi: 10.1098/rstb.2012.0106.
7
PAK1 kinase promotes cell motility and invasiveness through CRK-II serine phosphorylation in non-small cell lung cancer cells.PAK1 激酶通过非小细胞肺癌细胞中 CRK-II 的丝氨酸磷酸化促进细胞迁移和侵袭。
PLoS One. 2012;7(7):e42012. doi: 10.1371/journal.pone.0042012. Epub 2012 Jul 27.
8
Perspective: Dynamics of receptor tyrosine kinase signaling complexes.观点:受体酪氨酸激酶信号复合物的动力学。
FEBS Lett. 2012 Aug 14;586(17):2575-9. doi: 10.1016/j.febslet.2012.05.002. Epub 2012 May 11.
9
Crk adaptor proteins act as key signaling integrators for breast tumorigenesis.Crk 衔接蛋白作为关键信号整合因子参与乳腺癌发生。
Breast Cancer Res. 2012 May 8;14(3):R74. doi: 10.1186/bcr3183.
10
The β1-integrin-p-FAK-p130Cas-DOCK180-RhoA-vinculin is a novel regulatory protein complex at the apical ectoplasmic specialization in adult rat testes.β1整合素-p-FAK-p130Cas-DOCK180-RhoA-纽蛋白是成年大鼠睾丸顶端外质特化处一种新型的调节蛋白复合物。
Spermatogenesis. 2011 Jan;1(1):73-86. doi: 10.4161/spmg.1.1.15452.
Proc Natl Acad Sci U S A. 1981 Mar;78(3):1624-8. doi: 10.1073/pnas.78.3.1624.
4
Evidence that the phosphorylation of tyrosine is essential for cellular transformation by Rous sarcoma virus.有证据表明酪氨酸磷酸化对于劳氏肉瘤病毒引起的细胞转化至关重要。
Cell. 1980 Jul;20(3):807-16. doi: 10.1016/0092-8674(80)90327-x.
5
Changes in protein phosphorylation in Rous sarcoma virus-transformed chicken embryo cells.劳氏肉瘤病毒转化的鸡胚细胞中蛋白质磷酸化的变化。
Mol Cell Biol. 1981 Feb;1(2):165-78. doi: 10.1128/mcb.1.2.165-178.1981.
6
Enhancement of cellular src gene product associated tyrosyl kinase activity following polyoma virus infection and transformation.多瘤病毒感染和转化后细胞src基因产物相关酪氨酸激酶活性的增强。
Cell. 1984 Oct;38(3):767-77. doi: 10.1016/0092-8674(84)90272-1.
7
Rapid transformation of cells by Rous sarcoma virus.劳氏肉瘤病毒对细胞的快速转化
Proc Natl Acad Sci U S A. 1969 Jun;63(2):318-25. doi: 10.1073/pnas.63.2.318.
8
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes.利用噬菌体T7 RNA聚合酶指导克隆基因的选择性高水平表达。
J Mol Biol. 1986 May 5;189(1):113-30. doi: 10.1016/0022-2836(86)90385-2.
9
Vectors for selective expression of cloned DNAs by T7 RNA polymerase.用于通过T7 RNA聚合酶选择性表达克隆DNA的载体。
Gene. 1987;56(1):125-35. doi: 10.1016/0378-1119(87)90165-x.
10
Phospholipase C-148: chromosomal location and deletion mapping of functional domains.
Cold Spring Harb Symp Quant Biol. 1988;53 Pt 2:915-20. doi: 10.1101/sqb.1988.053.01.105.